The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 06, 2018

Filed:

Apr. 01, 2015
Applicant:

Bayer Pharma Aktiengesellschaft, Berlin, DE;

Inventors:

Knut Eis, Berlin, DE;

Jens Ackerstaff, Düsseldorf, DE;

Sarah Wagner, Berlin, DE;

Daniel Basting, Köln, DE;

Stefan Golz, Mülheim an der Ruhr, DE;

Eckhard Bender, Langenfeld, DE;

Volkhart Min-Jian Li, Velbert, DE;

Philip Lienau, Berlin, DE;

Ningshu Liu, Berlin, DE;

Franziska Siegel, Berlin, DE;

Marcus Bauser, Berlin, DE;

Detlev Sülzle, Berlin, DE;

Simon Holton, Berlin, DE;

Michaela Bairlein, Wuppertal, DE;

Philipp Buchgraber, Berlin, DE;

József Bálint, Berlin, DE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 233/90 (2006.01); C07D 263/34 (2006.01); C07D 401/12 (2006.01); C07D 413/12 (2006.01); A61K 31/541 (2006.01); C07D 295/092 (2006.01); C07D 403/06 (2006.01); C07D 403/12 (2006.01); C07D 407/12 (2006.01); C07D 413/06 (2006.01); C07D 487/10 (2006.01); C07D 491/107 (2006.01); A61K 31/4164 (2006.01); A61K 31/4178 (2006.01); A61K 31/421 (2006.01); A61K 31/4439 (2006.01); A61K 31/454 (2006.01); A61K 31/4545 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); A61K 31/5355 (2006.01); A61K 45/06 (2006.01); C07D 405/12 (2006.01); C07D 409/12 (2006.01);
U.S. Cl.
CPC ...
A61K 31/541 (2013.01); A61K 31/4164 (2013.01); A61K 31/4178 (2013.01); A61K 31/421 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/4545 (2013.01); A61K 31/496 (2013.01); A61K 31/497 (2013.01); A61K 31/5355 (2013.01); A61K 45/06 (2013.01); C07D 233/90 (2013.01); C07D 263/34 (2013.01); C07D 295/092 (2013.01); C07D 401/12 (2013.01); C07D 403/06 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 407/12 (2013.01); C07D 409/12 (2013.01); C07D 413/06 (2013.01); C07D 413/12 (2013.01); C07D 487/10 (2013.01); C07D 491/107 (2013.01);
Abstract

The present invention relates to amido-substituted azole compounds of general formula (I), in which X, X, R, R, R, R, Rand Rare as defined in the claims which are inhibitors of TNKS1 and/or TNKS2, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients.


Find Patent Forward Citations

Loading…